↓ Skip to main content

Dove Medical Press

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
2 news outlets
twitter
1 X user
patent
1 patent
video
1 YouTube creator

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
50 Mendeley
Title
Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges
Published in
Therapeutics and Clinical Risk Management, December 2020
DOI 10.2147/tcrm.s292504
Pubmed ID
Authors

Celina Dubin, Ester Del Duca, Emma Guttman-Yassky

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 12%
Researcher 6 12%
Student > Ph. D. Student 4 8%
Student > Postgraduate 3 6%
Student > Master 3 6%
Other 5 10%
Unknown 23 46%
Readers by discipline Count As %
Medicine and Dentistry 9 18%
Nursing and Health Professions 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Biochemistry, Genetics and Molecular Biology 2 4%
Social Sciences 2 4%
Other 4 8%
Unknown 25 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2024.
All research outputs
#1,809,744
of 26,329,145 outputs
Outputs from Therapeutics and Clinical Risk Management
#70
of 1,336 outputs
Outputs of similar age
#47,866
of 533,959 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#4
of 19 outputs
Altmetric has tracked 26,329,145 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,336 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 533,959 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.